Literature DB >> 7490534

Glucose activation of acetyl-CoA carboxylase in association with insulin secretion in a pancreatic beta-cell line.

S Zhang1, K H Kim.   

Abstract

Malonyl-CoA, which is the unique product of acetyl-CoA carboxylase (ACC), may serve as a metabolic coupler in glucose-stimulated insulin secretion by pancreatic beta-cells. Therefore we examined if and how ACC is affected by glucose in association with insulin secretion. Glucose induces a rapid increase in ACC activity which is closely related to insulin secretion in a dose- and time-dependent manner. The acute effect of glucose in increasing ACC activity is caused by dephosphorylation of existing ACC molecules, without the production of new enzyme. Inhibition of ACC dephosphorylation and activation by the use of okadaic acid led to diminished glucose-mediated insulin secretion. Likewise, when ACC phosphorylation and inactivation were induced by the use of 5-amino 4-imidazole-carboxamide ribotide, an AMP analog and activator of 5'-AMP protein kinase, the glucose-induced insulin secretion was virtually nil. In the long term, glucose induced ACC and increased insulin secretion. In beta-cells, ACC gene expression is controlled by promoter II and glucose activated promoter II expression. ACC promoter I is not expressed in beta-cells. Maximum activation of ACC and insulin secretion by glucose in the short term occurred at 5 mM glucose. On the other hand, activation of the expression of ACC promoter II occurred when the cells were exposed to high glucose concentrations for a long period of time. Thus, we have shown that ACC, the only enzyme that produces malonyl-CoA, is activated by glucose; activation of ACC is accomplished by dephosphorylation in the short term and by induction of ACC by gene activation in the long term.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490534     DOI: 10.1677/joe.0.1470033

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  12 in total

Review 1.  Lipid-associated metabolic signalling networks in pancreatic beta cell function.

Authors:  Marc Prentki; Barbara E Corkey; S R Murthy Madiraju
Journal:  Diabetologia       Date:  2019-08-19       Impact factor: 10.122

2.  Cloning of human acetyl-CoA carboxylase-beta and its unique features.

Authors:  J Ha; J K Lee; K S Kim; L A Witters; K H Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 3.  AMP-activated protein kinase signaling in metabolic regulation.

Authors:  Yun Chau Long; Juleen R Zierath
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 4.  Regulation of insulin secretion: role of mitochondrial signalling.

Authors:  S Jitrapakdee; A Wutthisathapornchai; J C Wallace; M J MacDonald
Journal:  Diabetologia       Date:  2010-03-12       Impact factor: 10.122

5.  AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release.

Authors:  I P Salt; G Johnson; S J Ashcroft; D G Hardie
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

6.  Activation of AMPK Stimulates Neurotensin Secretion in Neuroendocrine Cells.

Authors:  Jing Li; Jun Song; Heidi L Weiss; Todd Weiss; Courtney M Townsend; B Mark Evers
Journal:  Mol Endocrinol       Date:  2015-11-03

7.  Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression.

Authors:  Gabriela da Silva Xavier; Isabelle Leclerc; Aniko Varadi; Takashi Tsuboi; S Kelly Moule; Guy A Rutter
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

Review 8.  Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis.

Authors:  Guy A Rutter; Gabriela Da Silva Xavier; Isabelle Leclerc
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

9.  Metabolome response to glucose in the β-cell line INS-1 832/13.

Authors:  Matthew A Lorenz; Mahmoud A El Azzouny; Robert T Kennedy; Charles F Burant
Journal:  J Biol Chem       Date:  2013-02-20       Impact factor: 5.157

10.  Whole genome SNP genotyping and exome sequencing reveal novel genetic variants and putative causative genes in congenital hyperinsulinism.

Authors:  Maria Carla Proverbio; Eleonora Mangano; Alessandra Gessi; Roberta Bordoni; Roberta Spinelli; Rosanna Asselta; Paola Sogno Valin; Stefania Di Candia; Ilaria Zamproni; Cecilia Diceglie; Stefano Mora; Manuela Caruso-Nicoletti; Alessandro Salvatoni; Gianluca De Bellis; Cristina Battaglia
Journal:  PLoS One       Date:  2013-07-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.